Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

Volume: 382, Issue: 23, Pages: 2187 - 2196
Published: May 29, 2020
Abstract
Background Injectable luteinizing hormone–releasing hormone agonists (e.g., leuprolide) are the standard agents for achieving androgen deprivation for prostate cancer despite the initial...
Paper Fields
Paper Details
Title
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
Published Date
May 29, 2020
Volume
382
Issue
23
Pages
2187 - 2196
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.